ImmunoGen, Inc. provides earnings guidance for the year 2022. For the period, the company expects revenues between $75 million and $85 million.
1st Jan change | Capi. | |
---|---|---|
+23.10% | 52.73B | |
+37.49% | 39B | |
-8.62% | 38.52B | |
+28.09% | 30.38B | |
-12.26% | 26.39B | |
+10.63% | 26.08B | |
+45.05% | 14.15B | |
+32.31% | 12.6B | |
-6.63% | 11.51B |